Move to Cure

Move to Cure and BioRICS have a long relationship which started at AC Milan in 2006.

Today, Lieven Maesschalck (CEO Move to Cure) visited Daniel Berckmans (CTO BioRICS) to learn about Mindstretch and how this technology can make a difference in rehab.

The interview can be watched in 3 short video’s on Move to Cure’s Facebook page.